Found 15 matching trials
Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder
PHASE2To evaluate the efficacy of SPD489 compared to placebo in the treatment of ...
Location
Clinical Study Centers, LLC
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms
PHASE2To explore the efficacy of SPD489, as adjunctive therapy to a stable dose o...
Location
K&S Professional Research Services
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
PHASE3The primary objective of the study is to demonstrate the efficacy of SPD489...
Location
Radiant Research, Inc.
Open Label Extension in Adults With Binge Eating Disorder (BED)
PHASE3To evaluate the safety and tolerability of SPD489 administered as a daily m...
Location
Birmingham Research Group
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
PHASE3This study will examine SPD489 in subjects aged 18-65 with major depressive...
Location
ResearchOne, Inc.
Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
PHASE3To evaluate maintenance of efficacy based on time to relapse between SPD489...
Location
Gulfcoast Clinical Research Center
Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss
PHASE2This is a double-blind, single center, parallel group, placebo and active c...
Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
PHASE3To evaluate the efficacy of LDX compared to placebo in adults with ADHD in ...
Location
Clinical Study Centers, LLC
Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
PHASE4While the Lisdexamfetamine Dimesylate (SPD489) clinical program has studied...
Location
ZNA Antwerpen, Commandant Weynsstraat 165 Campus Hoge Beuken
SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia
PHASE3To assess the safety and efficacy of SPD489 low-dose and high-dose treatmen...
Location
Multiple Locations